87
Participants
Start Date
May 16, 2023
Primary Completion Date
October 12, 2024
Study Completion Date
March 26, 2025
telehealth-based clinical pharmacy intervention
The pharmacist will perform an initial comprehensive review of the medication regimen, make any adjustments, document those in the patient's electronic health record (EHR) and communicate with the patient's T2D care team as needed. They will also call (using an EHR-based software) the patient using phone/video to educate them about T2D self-management and identify any medication-related unmet needs. Periodic reviews of the medication regimen and roughly biweekly follow-up patient calls will occur with frequency based on need (as judged by the pharmacist). Patient intervention calls will be personalized depending on HbA1c levels, comorbidities, and medication complexity
Wake Forest University Health Sciences, Winston-Salem
Collaborators (1)
Duke University
OTHER
Wake Forest University Health Sciences
OTHER